Hilton Capital Management’s Exact Sciences EXAS Stock Holding History

Hilton Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-30	Closed	-$2K	–	361
2018 Q2	$2K	Buy	+30	New	+$1.61K	﹤0.01%	374

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hilton Capital Management's EXAS Position: Q3 2018 in Review

Hilton Capital Management sold out of Exact Sciences (EXAS) in Q3 2018, closing a stake of 30 shares — an estimated $2K sold.

Hilton Capital Management first reported a position in EXAS in Q2 2018 and held it in 1 quarter. The position peaked at $2K in Q2 2018. 365 funds tracked by Wall St. Rank hold EXAS as of Q3 2018.

Hilton Capital Management reported no remaining Exact Sciences position as of Q3 2018 after selling out during the quarter.
Hilton Capital Management sold 30 Exact Sciences shares in Q3 2018, an estimated $2K.
Hilton Capital Management first reported a position in Exact Sciences in Q2 2018 and held it in 1 quarter.
Hilton Capital Management's Exact Sciences position peaked at $2K in Q2 2018.
365 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2018.

Based on Hilton Capital Management's 13F filing for Q3 2018, filed 9 Nov 2018.